E2F3 and hepatocellular carcinoma: Since CD36/AKT pathway was activated in MFs, we performed WB to demonstrate that CD36 and p-AKT were reduced in E2F3 F/F cre HCC compared to E2F3 + / + cre HCC (P < 0.05 by t-test, Fig. 7E).